Literature DB >> 3552016

Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.

P Hendy-Ibbs, H Cox, G I Evan, J V Watson.   

Abstract

The c-myc nuclear associated oncoprotein has been quantitated simultaneously with DNA in nuclei extracted from archival biopsies of uterine cervix neoplasia. The oncoprotein and DNA were measured fluorimetrically in a flow cytometer using a mouse monoclonal antibody (MYC 1-6E10) and propidium iodide. Normal biopsies exhibited higher oncoprotein levels than carcinomas (P less than 0.00001). Furthermore, the maximum fluorescence signal in the normal tissue occurred at a lower antibody concentration compared with tumour tissue. There was no correlation between oncoprotein levels and histological grade, stage of disease, age of the patients or prognosis in the carcinomas. Aneuploidy, defined as a distinct second peak separate from the diploid distribution, was not a significant feature. The c-myc oncoprotein nuclear content does not appear to be a prognostic indicator in carcinoma of the cervix from the results of these studies but there is clearly diagnostic potential, particularly for automated analysis of cervical screening.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552016      PMCID: PMC2001762          DOI: 10.1038/bjc.1987.53

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  33 in total

1.  Detection of suspicious cells and rejection of artefacts in cervical cytology using the Leyden Television Analysis System.

Authors:  I Al; J S Ploem
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

2.  Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.

Authors:  H L Niman; R A Houghten; L E Walker; R A Reisfeld; I A Wilson; J M Hogle; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

3.  Enzyme kinetic studies in cell populations using fluorogenic substrates and flow cytometric techniques.

Authors:  J V Watson
Journal:  Cytometry       Date:  1980-09

4.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  Flow cytometry of human gynecologic specimens using log chromomycin A3 fluorescence and log 90 degrees light scatter.

Authors:  D L Barrett; R H Jensen; E B King; P N Dean; B H Mayall
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

6.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

7.  Dual laser beam focussing for flow cytometry through a single crossed cylindrical lens pair.

Authors:  J V Watson
Journal:  Cytometry       Date:  1981-07

8.  Flow cytometric prescreening of cervical smears.

Authors:  W A Linden; K Ochlich; H Baisch; K U Scholz; H J Mauss; H E Stegner; D S Joshi; C T Wu; I Koprowska; C Nicolini
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

9.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor.

Authors:  R F Doolittle; M W Hunkapiller; L E Hood; S G Devare; K C Robbins; S A Aaronson; H N Antoniades
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

10.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus.

Authors:  M D Waterfield; G T Scrace; N Whittle; P Stroobant; A Johnsson; A Wasteson; B Westermark; C H Heldin; J S Huang; T F Deuel
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

View more
  13 in total

1.  Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.

Authors:  S Rowley; K M Newbold; J Gearty; M R Keighley; I A Donovan; J P Neoptolemos
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

2.  Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

Authors:  V Sundaresan; I C Forgacs; D G Wight; B Wilson; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  c-myc oncoprotein levels in bladder cancer.

Authors:  J R Masters; S G Vesey; C F Munn; G I Evan; J V Watson
Journal:  Urol Res       Date:  1988

4.  Papillomavirus and c-myc antigen expression in normal and neoplastic cervical epithelium.

Authors:  R G Hughes; W A Neill; M Norval
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

5.  Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

Authors:  M Curling; S Stenning; C N Hudson; J V Watson
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

6.  Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.

Authors:  S V Polacarz; J Darne; E G Sheridan; R Ginsberg; F Sharp
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

7.  C-myc oncogene expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; K Rogers; F Sharp; J H Smith; S V Polacarz
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

8.  c-myc oncogene product expression and prognosis in operable breast cancer.

Authors:  A P Locker; C S Dowle; I O Ellis; C W Elston; R W Blamey; K Sikora; G Evan; R A Robins
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

9.  Reactivity of monoclonal antibodies to oncoproteins with normal rat liver, carcinogen-induced tumours, and premalignant liver lesions.

Authors:  M J Embleton; P C Butler
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

10.  Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.

Authors:  B S Bolger; T G Cooke; R P Symonds; A B MacLean; P D Stanton
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.